Industry: Pharmaceuticals, Biotechnology
Immunicon is developing and commercializing diagnostic and research products for rare cell analysis, with an initial focus on cancer. Reagent kits incorporating Immunicon proprietary technology are used with our instrument systems to capture, count and characterize circulating tumor cells or circulating endothelial cells from whole blood. ( www.immunicon.com )
Immunicon Corporation
3401 Masons Mill Road Suite 100
Huntingdon Valley, Pennsylvania 19006
USA
Tel: (215) 830-0777
Fax: (215) 830-0751